Tag: on

Carryover Effects and Their Impact on Validity – Clinical Trial Design and Protocol Development

Posted on digi By digi

Carryover Effects and Their Impact on Validity – Clinical Trial Design and Protocol Development “Implications of Carryover Effects on Validity” Introduction In clinical research, ensuring the validity of results is of utmost importance. One factor that can significantly impact the validity of study outcomes is the concept of ‘Carryover Effects’. Understanding these effects and how…

Read More “Carryover Effects and Their Impact on Validity – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Crossover Trials

Regulatory Guidelines on Adaptive Designs (FDA, EMA) – Clinical Trial Design and Protocol Development

Posted on digi By digi

Regulatory Guidelines on Adaptive Designs (FDA, EMA) – Clinical Trial Design and Protocol Development “Adaptive Design Regulations as per FDA and EMA Guidelines” Introduction Adaptive designs are a crucial component of clinical studies, allowing for modifications to the trial after it commences without undermining the validity and integrity of the study. Two primary regulatory bodies,…

Read More “Regulatory Guidelines on Adaptive Designs (FDA, EMA) – Clinical Trial Design and Protocol Development” »

Adaptive Trial Designs, Clinical Trial Design and Protocol Development